Kapur Anil

Verastem, Inc. · Director

Kapur Anil is listed in filings as Director at Verastem, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to Verastem, Inc. (VSTM), Nurix Therapeutics, Inc. (NRIX), and Geron Corporation (GERN). The current snapshot covers public activity from Jun 12, 2024 to May 26, 2026. Reported amounts are shown as $495.6K to $237.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Geron CorporationGERN$2M421.9k sharesSellJun 10, 2024$4.65$1.42